Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

Acta Oncol. 2009;48(1):158-9. doi: 10.1080/02841860802266672.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / complications
  • Bone Neoplasms / drug therapy*
  • Cervical Vertebrae / pathology
  • Cetuximab
  • Chordoma / complications
  • Chordoma / drug therapy
  • Female
  • Gefitinib
  • Humans
  • Middle Aged
  • Quinazolines / administration & dosage
  • Quinazolines / adverse effects
  • Spinal Cord Compression / drug therapy*
  • Spinal Cord Compression / etiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Quinazolines
  • Cetuximab
  • Gefitinib